Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/99314
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors |
Author: | McGeachie, A. Odell, L. Quan, A. Daniel, J. Chau, N. Hill, T. Gorgani, N. Keating, D. Cousin, M. van Dam, E. Mariana, A. Whiting, A. Perera, S. Novelle, A. Young, K. Deane, F. Gilbert, J. Sakoff, J. Chircop, M. McCluskey, A. et al. |
Citation: | ACS Chemical Biology, 2013; 8(7):1507-1518 |
Publisher: | American Chemical Society |
Issue Date: | 2013 |
ISSN: | 1554-8929 1554-8937 |
Statement of Responsibility: | Andrew B. McGeachie, Luke R. Odell, Annie Quan, James A. Daniel, Ngoc Chau, Timothy A. Hill, Nick N. Gorgani, Damien J. Keating, Michael A. Cousin, Ellen M. van Dam, Anna Mariana, Ainslie Whiting, Swetha Perera, Aimee Novelle, Kelly A. Young, Fiona M. Deane, Jayne Gilbert, Jennette A. Sakoff, Megan Chircop, Adam McCluskey, and Phillip J. Robinson |
Abstract: | Dynamin is required for clathrin-mediated endocytosis (CME). Its GTPase activity is stimulated by phospholipid binding to its PH domain, which induces helical oligomerization. We have designed a series of novel pyrimidine-based “Pyrimidyn” compounds that inhibit the lipid-stimulated GTPase activity of full length dynamin I and II with similar potency. The most potent analogue, Pyrimidyn 7, has an IC50 of 1.1 μM for dynamin I and 1.8 μM for dynamin II, making it among the most potent dynamin inhibitors identified to date. We investigated the mechanism of action of the Pyrimidyn compounds in detail by examining the kinetics of Pyrimidyn 7 inhibition of dynamin. The compound competitively inhibits both GTP and phospholipid interactions with dynamin I. While both mechanisms of action have been previously observed separately, this is the first inhibitor series to incorporate both and thereby to target two distinct domains of dynamin. Pyrimidyn 6 and 7 reversibly inhibit CME of both transferrin and EGF in a number of non-neuronal cell lines as well as inhibiting synaptic vesicle endocytosis (SVE) in nerve terminals. Therefore, Pyrimidyn compounds block endocytosis by directly competing with GTP and lipid binding to dynamin, limiting both the recruitment of dynamin to membranes and its activation. This dual mode of action provides an important new tool for molecular dissection of dynamin’s role in endocytosis. |
Keywords: | COS Cells Animals Pyrimidines Dynamins Blotting, Western Biological Assay Flow Cytometry Endocytosis Molecular Structure Protein Binding Drug Design Small Molecule Libraries Chlorocebus aethiops |
Rights: | © 2013 American Chemical Society |
DOI: | 10.1021/cb400137p |
Published version: | http://dx.doi.org/10.1021/cb400137p |
Appears in Collections: | Aurora harvest 7 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.